This modulation alters the expression of proteins like B-cell lymphoma-2 (Bcl-2), CyclinD1, and PCNA, underscoring the role of HNRNPA2B1 in glioma cell proliferation and its therapeutic potential [181,182,183]. The gene discussed is HNRNPA2B1; the disease is central nervous system cancer.